Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-28

FDA Approved: LACOSAMIDE ORAL SOLUTION — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application to authorize lacosamide oral solution from Ascend Laboratories, expanding the product's dosage form.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide oral solution (lacosamide)

Snippet

SUPPL AP for LACOSAMIDE ORAL SOLUTION (LACOSAMIDE ORAL SOLUTION)